Wire Stories
Zai Lab Announces Inclusion of QINLOCK� (ripretinib) and NUZYRA� (omadacycline) in China�s National Reimbursement Drug List
SHANGHAI and CAMBRIDGE, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global...